Company: ANIX
Filing Date: 2025-09-10
Form Type: S-3
Source: 0001493152-25-013010
Chunk: 58

Company: Anixa Biosciences Inc
Filing Date: 2025-09-10
Form: S-3
Chunk 58
---
us to any of our contracts, agreements or other documents, the reference may not be complete and you should refer to the exhibits that are a part of the registration statement or the exhibits to the reports or other documents incorporated by reference into this prospectus for a copy of such contract, agreement or other document. Because we are subject to the information and reporting requirements of the Securities Exchange Act of 1934, as amended, or the Exchange Act, we file annual, quarterly and current reports, proxy statements and other information with the SEC. Our SEC filings are available to the public over the Internet at the SEC’s website at http://www.sec.gov.

<div align='center'>INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</div>

We are “incorporating by reference” in this prospectus certain documents we file with the SEC, which means that we can disclose important information to you by referring you to those documents. The information in the documents incorporated by reference is considered to be part of this prospectus. Statements contained in documents that we file with the SEC and that are incorporated by reference in this prospectus will automatically update and supersede information contained in this prospectus, including information in previously filed documents or reports that have been incorporated by reference in this prospectus, to the extent the new information differs from or is inconsistent with the old information. We have filed or may file the following documents with the SEC and they are incorporated herein by reference as of their respective dates of filing.

| 1. 
 2. | Our                                                                                           
 Annual Report on Form 10-K for the year ended October 31, 2024, filed with the SEC on January 
 10, 2025;                                                                                     
 Our                                                                                           
 Quarterly Report on Form 10-Q for the quarter ended January 31, 2025, filed with the SEC      
 on March 11, 2025;                                                                            |
|:---|:----------------------------------------------------------------------------------------------|
| 3. | Our                                                                                           
 Quarterly Report on Form 10-Q for the quarter ended April 30, 2025, filed with the SEC on     
 May 28, 2025;                                                                                 |
| 4. | Our                                                                                           
 Quarterly Report on Form 10-Q for the quarter ended July 31, 2025, filed with the SEC on      
 September 10, 2025;                                                                           |
| 5. | Our                                                                                           
 Definitive Proxy Statement on Schedule 14A filed with the SEC on February 6, 2025;            |